Lalit Ahuja , PHARM D MBA
Pharmacist • Manteca, CA
1721 W Yosemite Ave, Ccm Department
Manteca, CA 953375130
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on November 20, 2006; this date does not establish years in practice.
-
Published CMS data list 2,297 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ozempic (Semaglutide) — 498 prescription fills, including refills.
- Metformin Hcl Er (Metformin Hcl) — 196 prescription fills, including refills.
- Atorvastatin Calcium — 179 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 90% of clinicians listed under Pharmacist in Manteca, CA (2024, 12 clinicians with data). Median for this group: 114. Middle half: 76 to 874.
More Part D prescriptions than 95% of clinicians listed under Pharmacist in California (2024, 4,003 clinicians with data). Median for this group: 64. Middle half: 32 to 128.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,665 in 2020 to 2,297 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
1721 W Yosemite Ave
Ccm Department
Manteca, CA 953375130
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Pharmacist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
6,250 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$567,286 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Compared with the same specialty in Manteca and California
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Pharmacist in Manteca, CA (2024, 12 clinicians with data). Median for this group: 114. Middle half: 76 to 874.
More Part D prescriptions than 95% of clinicians listed under Pharmacist in California (2024, 4,003 clinicians with data). Median for this group: 64. Middle half: 32 to 128.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Pharmacist in Manteca, CA (2024, 12 clinicians with data). Median for this group: $21,936. Middle half: $16,814 to $93,697.
A higher Part D drug cost than 95% of clinicians listed under Pharmacist in California (2024, 4,003 clinicians with data). Median for this group: $13,313. Middle half: $6,221 to $25,067.
85 active clinicians are listed under Pharmacist with a practice address in Manteca, CA (33,053 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Manteca
0% of these 85 clinicians have the CMS telehealth indicator.
0% of these 85 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 38% from 1,665 in 2020 to 2,297 in 2024.
- 2020: 1,665
- 2021: 1,597
- 2022: 1,852
- 2023: 2,190
- 2024: 2,297
-
30-day fills
30-day fills increased 20% from 5,227 in 2020 to 6,250 in 2024.
- 2020: 5,227
- 2021: 4,964
- 2022: 5,720
- 2023: 6,468
- 2024: 6,250
-
Part D drug cost
Part D drug cost increased 203% from $187,054 in 2020 to $567,286 in 2024.
- 2020: $187,054
- 2021: $314,618
- 2022: $507,411
- 2023: $584,124
- 2024: $567,286
Sources: CMS Medicare Part D Prescribers (2024), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ozempic | Semaglutide | 498 | 14,380 | $369,343.55 | 85 |
| Metformin Hcl Er | Metformin Hcl | 196 | 19,445 | $1,909.35 | 87 |
| Atorvastatin Calcium | Atorvastatin Calcium | 179 | 17,684 | $2,160.96 | 84 |
| Glipizide | Glipizide | 171 | 16,730 | $2,049.12 | 71 |
| Jardiance | Empagliflozin | 158 | 15,560 | $100,768.93 | 77 |
| Metformin Hcl | Metformin Hcl | 144 | 14,350 | $1,778.94 | 67 |
| Glipizide Er | Glipizide | 105 | 10,500 | $2,560.12 | 45 |
| Humulin N | Insulin Nph Human Isophane | 78 | 7,013 | $16,644.36 | 38 |
| Losartan Potassium | Losartan Potassium | 73 | 7,300 | $863.94 | 36 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 72 | 5,752 | $12,587.31 | 37 |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 69 | 5,371 | $14,862.60 | 23 |
| Amlodipine Besylate | Amlodipine Besylate | 46 | 4,550 | $512.41 | 21 |
| Humalog Kwikpen U-100 | Insulin Lispro | 45 | 3,306 | $18,272.10 | 17 |
| Veo Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 43 | 4,170 | $1,122.26 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 39 | 3,880 | $457.13 | 18 |
| Humulin R | Insulin Regular, Human | 39 | 3,529 | $7,820.38 | 23 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 37 | 3,530 | $953.52 | 20 |
| Lisinopril | Lisinopril | 34 | 3,400 | $456.81 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 28 | 2,800 | $303.17 | 11 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 28 | 2,520 | $874.24 | 13 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 27 | 2,440 | $4,724.51 | 12 |
| Simvastatin | Simvastatin | 26 | 2,600 | $303.42 | 13 |
| Glimepiride | Glimepiride | 26 | 2,195 | $386.11 | — |
| Veo Insulin Syringe | Syringe And Needle,insulin,1ml | 21 | 2,100 | $724.68 | — |
| Metoprolol Succinate | Metoprolol Succinate | 20 | 2,000 | $242.60 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 183500000X
An individual licensed by the appropriate state regulatory agency to engage in the practice of pharmacy. The practice of pharmacy includes, but is not limited to, assessment, interpretation, evaluation, and implementation, initiation, monitoring or modification of medication and or medical orders; the compounding or dispensing of medication and or medical orders; participation in drug and device procurement, storage, and selection; drug administration; drug regimen reviews; drug or drug-related research; provision of patient education and the provision of those acts or services necessary to provide medication therapy management services in all areas of patient care.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Pharmacist - Oncology
Doctor of Pharmacy (Pharm.D.)
Career & Practice History
NPI enumerated November 20, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Pharmacists in Manteca
All Pharmacists in MantecaMailing Address
10230 Windmill Cove Dr
Stockton, CA 952094332